// COMPANY
IMU Biosciences
SECTOR BIOTECHMENTIONS 2LAST SEEN JUNE 8, 2026
// OVERVIEW
Biotech company focused on multi-omic immune profiling.
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PostRound·JUNE 8, 2026
“IMU Biosciences raised $38.3 million... Discovery engine mapping the immune system for precision medicine.”
Source→02
funding·StrictlyVC·JUNE 3, 2026
“IMU Biosciences raised $38.4M for multi-omic immune profiling.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.